Quinazoline-based VEGFR-2 inhibitors as potential anti-angiogenic agents: A contemporary perspective of SAR and molecular docking studies
Mahfam Moradi, Alireza Mousavi, Zahra Emamgholipour, Johanna Giovannini, Setareh Moghimi, Fariba Peytam, Amin Honarmand, Stéphane Bach, Alireza Foroumadi
Topics & Concepts
VandetanibAngiogenesisQuinazolineSorafenibChemistryPharmacologyTyrosine kinaseDrug discoveryCancer researchKinaseRegulatorMedicineSignal transductionBiochemistryGeneCombinatorial chemistryHepatocellular carcinomaAngiogenesis and VEGF in CancerCancer Mechanisms and TherapyHER2/EGFR in Cancer Research